Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5467
Source ID: NCT01087242
Associated Drug: Tang-Min Lin Pill
Title: Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes Mellitus
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Tang-min Lin pill
Outcome Measures: Primary: glycosylated hemoglobin, 0 and 12weeks after treatment | Secondary: fasting blood glucose,2-hour postprandial blood glucose,true insulin,TG,TG、LCL-C、HDL-C、BMI,waistline, hipline,TCM syndrome and sign, baseline and 12 week after treatment
Sponsor/Collaborators: Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Collaborators: Tianjin University of Traditional Chinese Medicine|Liaoning University of Traditional Chinese Medicine|Shanghai University of Traditional Chinese Medicine|Beijing Hospital|Tianjin Tasly Pharmaceutical Co., Ltd
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 480
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2009-05
Completion Date: 2010-06
Results First Posted:
Last Update Posted: 2010-03-16
Locations: TCM school of Jiang Su province, Nan Jing, Jiang Su, 210029, China|Liaoning University of Traditional Chinese Medicine, Shen Yang, Liao Ning, 116600, China|Shanghai University of Traditional Chinese Medicine, Shang Hai, Shang Hai, 200032, China|Tian Jin traditional chinese medicine university, Tian Jin, Tian Jin, 300193, China
URL: https://clinicaltrials.gov/show/NCT01087242